Here are relevant reports on : peptide-therapeutics-market
-
Wireless Devices Market for Medical by Technology (BT/BLE, Wi-Fi, ZigBee, ANT+), Component (Sensors, ICs, Processors), Application (Monitoring, Medical Therapeutics, Diagnosis, Fitness & Wellness), and Geography – Global Forecast to 2020
Wireless portable medical devices, which are widely used in applications such as monitoring, medical therapeutics, diagnosis, and fitness and wellness, have proved to be very useful to cater to the growing need of advanced healthcare services. Portable medical electronics have proved to be a boon to medical science as it plays an important role in overall diagnosis and patient monitoring activities.
- Published: December 2014
- Price: $ 4950
- TOC Available:
-
Human Microbiome Drugs Market by Type (Live Biotherapeutic Products, Fecal Microbiota-derived Therapeutics), Disease (Gastrointestinal, Infectious), End User (Hospitals, Clinics, Long-term Care) - Global Forecast to 2031
The human microbiome drugs market, valued at US$0.09 billion in 2024, stood at US$0.35 billion in 2025 and is projected to advance at a resilient CAGR of 35.2% from 2025 to 2031, culminating in a forecasted valuation of US$2.13 billion by the end of the period. The human microbiome drugs market is growing, driven by the increasing clinical success of live biotherapeutic products, rising prevalence of chronic and recurrent diseases, and expanding therapeutic applications beyond gastrointestinal disorders into metabolic, immune, and neurological conditions.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Europe Medical Gas and Equipment Market by Type [Medical Gas (Oxygen, Nitrous Oxide), Medical Gas Equipment (Flowmeter, Others)], Application [Therapeutics, Diagnostics], End User [Hospital, Home Healthcare] - Regional Forecast to 2031
The Europe Medical Gas and Equipment Market, valued at US5D .71 billion in 2024, stood at USD 6.00 billion in 2025 and is projected to advance at a resilient CAGR of 5.3% from 2025 to 2031, culminating in a forecasted valuation of USD 8.19 billion by the end of the period. The Europe medical gas and equipment market is expanding because of factors such as healthcare demand resulting from an aging population, the prevalence of chronic and respiratory diseases, and higher surgical and ICU volumes.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Antibody Therapeutics Market by Format (Monoclonal, Polyclonal, Antibody Fragment, Bispecific), Disease Area (Oncology, Autoimmune & Inflammatory, Neurology, Hematology, Infectious), Source (Human, Chimeric), Route (IV, SC) & Region - Global Forecast to 2028
The global antibody therapeutics market, valued at US$217.6 billion in 2022, stood at US$247.3 billion in 2023 and is projected to advance at a resilient CAGR of 14.1% from 2023 to 2028, culminating in a forecasted valuation of US$479.0 billion by the end of the period. Growth in the antibody therapeutics market is mainly driven by factors such as growing advancements in antibody engineering for development of novel therapeutics, growing R&D activities among others
- Published: December 2023
- Price: $ 4950
- TOC Available:
-
Bioconjugation Market by Product (Consumables, Instruments (Chromatography, Spectrometry)), Service (Conjugation, Analytical), Technique (Chemical, Click Chemistry), Biomolecule (Antibodies), Application (Therapeutics (ADC), R&D) - Global Forecast to 2029
The global bioconjugation market, valued at US$4.78 billion in 2023, stood at US$5.27 billion in 2024 and is projected to advance at a resilient CAGR of 15.6% from 2024 to 2029, culminating in a forecasted valuation of US$10.86 billion by the end of the period. The bioconjugation market is experiencing significant growth with the advancement of bioconjugation technologies, which increase precision, efficacy, and safety in therapeutic & diagnostic applications.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Osteoarthritis Therapeutics Market by Anatomy (Knee, Hand), Drug Type (NSAIDs, Analgesics, Corticosteroids), Route of Administration (Parenteral), Distribution Channel (Hospital Pharmacies), Purchasing Pattern (Prescription Drugs) - Global Forecasts to 2025
The global osteoarthritis therapeutics market growth is primed to transition from USD 7.3 billion in 2020 to USD 11.0 million by 2025, showcasing a strong CAGR of 8.7%.
- Published: December 2020
- Price: $ 4950
- TOC Available:
-
Medical Gas and Equipment Market by Type [Medical Gas (Oxygen, Nitrous Oxide), Medical Gas Equipment (Flowmeter, Others)], Application [Therapeutics, Diagnostics], End User (Hospital, Home Healthcare]-Global Forecast to 2031
The medical gas and equipment market, valued at USD 19.90 billion in 2024, stood at USD 21.03 billion in 2025 and is projected to advance at a resilient CAGR of 6.2% from 2025 to 2031, culminating in a forecasted valuation of US$30.05 billion by the end of the period. The medical gas and equipment market is witnessing constant growth as a result of the rising demand for advanced healthcare services through hospitals, clinics, and homecare settings.
- Published: June 2026
- Price: $ 7150
- TOC Available:
-
Custom Antibody Market by Service (Development, Purification, Fragmentation, Labeling), Type (mAbs, pAbs, rAbs), Source (Rabbit, Mice), Application (Research, Therapeutics), Indication (Oncology, Immunology, Infectious, CVD) - Global Forecast to 2029
The global custom antibody market, valued at US$539 million in 2023, stood at US$579 million in 2024 and is projected to advance at a resilient CAGR of 9.2% from 2024 to 2029, culminating in a forecasted valuation of US$901 million by the end of the period. The market's growth is mainly driven by government funding and support for research in antibody-related fields, coupled with the expansion into translational medicine.
- Published: June 2024
- Price: $ 4950
- TOC Available:
-
mRNA Therapeutics Market by Product (Vaccines, Drugs), Application (Oncology, Rare Diseases, Infectious Diseases, Other Applications), End User (Hospitals & Clinics, Research Settings) - Global Forecast to 2027
The global mRNA therapeutics market is projected to reach USD ~35 billion by 2027 from USD 32 billion in 2022, at a CAGR of ~2% between 2022 and 2027.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Aptamers Market by Product Type (DNA, RNA, XNA), Technology (SELEX), Application (Therapeutics, Diagnostics, R&D), End Users (Pharmaceutical & Biotechnology Companies, Academic & Government Research Institutes, CROs) - Global Forecast to 2026
The global aptamers market growth is primed to transition from $151 million in 2021 to $342 million by 2026, showcasing a strong CAGR of 17.7%. Growth of the market is attributed to factors such as increase in number of clinical trials for development of aptamer-based therapeutics, increase in awareness about advantages of aptamers as compared to antibodies, rising investment in pharmaceutical R&D, and rising prevalence of chronic and rare diseases to increase the demand for aptamer-based therapeutics and diagnostics. Growth in the venture capital funding for research on aptamers and growing collaborations with research institutes and pharmaceutical companies are also expected to offer a wide range of growth opportunities to players in the market.
- Published: November 2021
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
